Intravenous Immunoglobulin Market By Product Type (Liquid and Lyophilized), By Application (Primary Immunodeficiency, Multifocal Motor Neuropathy (MMN), Immune Thrombocytopenic Purpura (ITP), Guillain-Barré Syndrome (GBS), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), and Others), By End-user (Hospitals, Clinics, and Homecare), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
Report Overview The Intravenous Immunoglobulin Market size is expected to be worth around US$ 28.1 billion by 2034 from US$ 13.9 billion in 2024, growing at a CAGR of 7.3% during the...
